Association of vascular amyloid β and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 3, 1997, Pages 273-284

  Maat Schieman, Marion L C ^a   Van Duinen, Sjoerd G ^a   Rozemuller, Annemieke J M ^b   Haan, Joost ^a,c   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RIJNLAND HOSPITAL   (Netherlands)

Author keywords

Alzheimer disease; Amyloid ; Cerebral amyloid angiopathy; Class II major histocompatibility antigen HLA DR; Hereditary cerebral hemorrhage with amyloidosis (Dutch); Mononuclear phagocyte system

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN;

ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; GENETIC DISORDER; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; HUMAN TISSUE; MONONUCLEAR CELL; NEUROPATHOLOGY; PHAGOCYTE; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS;

EID: 0030827642     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199703000-00006     Document Type: Article

References (69)

1. Haan J, Roos RAC, Briët P, Herpers MJHM, Luyendijk W, Bots GTAM. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: Clinical characteristics. Clin Neurol Neurosurg 1989;81:285-290
2. Haan J, Bakker E, Jennekens-Schinkel A, Roos RAC. Progressive dementia, without cerebral hemorrhage, in a patient with hereditary cerebral amyloid angiopathy. Clin Neurol Neurosurg 1992;94:317-18
3. Bornebroek M, Haan J, Maat-Schieman MLC, Van Duinen SG, Roos RAC. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I - A review of clinical, radiologic and genetic aspects. Brain Pathol 1996;6:111-14
4. Duinen SG van, Castaño EM, Prelli F, Bots GTAM, Luyendijk W, Frangione B. Hereditary cerebral hemorrhage with amyloidosis of Dutch origin is related to Alzheimer's disease. Proc Natl Acad Sci USA 1987;84:5991-94
5. Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-26
6. Bakker E, van Broeckhoven C, Haan J, et al. DNA Diagnosis for hereditary cerebral hemorrhage with amyloidosis (Dutch type). Am J Hum Genet 1991;49:518-21
7. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-24
8. Shoji M, Hirai S, Harigaya Y, Kawarabayashi T, Yamaguchi H. The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels. Brain Res 1990;530:113-16
9. Kawai M, Kalaria RN, Cras P, et al. Degeneration of vascular smooth muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 1993;623:142-46
10. Wisniewski HM, Wegiel J. β-Amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994;87:233-41
11. Van Nostrand WE, Rozemuller AJM, Chung R, Cotman CW, Saporito-Irwin SM. Amyloid β-protein precursor in cultured leptomeningeal smooth muscle cells. Amyloid: Int J Exp Clin Invest 1994;1:1-7
12. Wisniewski HM, Fraçkowiak J, Zóltowska A, Kim KS. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid. Int J Clin Invest 1994;1:8-16
13. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar β-amyioid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropathol Exp Neurol 1994;53:637-45
14. Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992;84:117-27
15. Hickey WF, Vass K, Lassmann H. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 1992;51:246-56
16. Verbeek MM, Otte-Höller I, Wesseling P, Van Nostrand WE, Sorg C, Ruiter DJ, de Waal RMW. A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta Neuropathol 1995;90:493-503
17. Graeber MB, Streit WJ, Büringer D, Sparks DL, Kreutzberg GW. Ultrastructural location of major histocompatibility complex (MHC) class II positive perivascular cells in histologically normal human brain. J Neuropathol Exp Neurol 1992;51:303-11
18. Banati RB, Gehrmann J, Czech C, et al. Early and rapid de novo synthesis of Alzheimer βA4-amyloid precursor protein (APP) in activated microglia. Glia 1993;9:199-210
19. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R. An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab Invest 1995;72:272-82
20. Snow AD, Kinsella MG, Parks E, et al. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 1995;320:84-95
21. Yamaguchi H, Yamazaki T, Lemere CA, Frosch MP, Selkoe DJ. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. Am J Pathol 1992;141:249-59
22. Gravina SA, Ho L, Eckman CB, et al. Amyloid β protein (Aβ) in Alzheimer's disease brain. J Biol Chem 1995;270:7013-16
23. Haass C, Schlossmacher MG, Hung AY, et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-26
24. Shoji M, Golde TE, Ghiso J, et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 1992;258:126-29
25. Seubert P, Vigo-Pelfrey C, Esch F, et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 1992;359:325-27
26. Martel CL, Makic JB, McComb JG, Ghiso J, Zlokovic BV. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid β in guinea pigs. Neurosci Lett 1996;206:157-60
27. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys 1993;301:41-52
28. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ. β-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: Implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 1993;90:10836-40
29. Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989;16:535-42
30. Ling E, Wong W. The origin and nature of ramified and amoeboid microglia: A historical review and current concepts. Glia 1993;7:9-18
31. Sievers J, Schmidtmayer, Parwaresch R. Blood monocytes and spleen macrophages differentiate into microglia-like cells when cultured on astrocytes. Ann Anat 1994;176:45-51
32. Maat-Schieman MLC, Rozemuller JM, van Duinen SG, Haan J, Eikelenboom P, Roos RAC. Microglia in diffuse plaques in hereditary cerebral hemorrhage with amyloidosis (Dutch). An immunohistochemical study. J Neuropathol Exp Neurol 1994;53:483-91
33. Kondoh H, Matsushita M, Kosaka K, Miyazaki N. Staining senile plaques using Bodian's method modified with methenamine. Biotechnic Histochem 1993;68:113-16
34. Allsop D, Landon M, Kidd M, Lowe JS, Reynolds GP, Gardner A. Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease. Neurosci Lett 1986;68:252-56
35. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against a-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787-96
36. Ghosh AK, Gatter KC, Mason DY. Immunocytochemical characterization of monoclonal anti-HLA-DR antibodies. In: Steel CM, ed. Disease markers. Sussex: John Wiley & Sons, Ltd., 1984:223-33
37. Marder RJ, Variakojis D, Silver J, Epstein AL. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin tissue. Lab Invest 1985;52:497-504
38. Warnke RA, Gatter KC, Falini B, et al. Diagnosis of human lymphoma with monoclonal antileukocyte antibodies. N Engl J Med 1983;309:1275-81
39. Schwarting R, Stein H, Wang CY. The monoclonal antibodies S-HCL1 (Leu 14) and S-HCL3 (Leu M5) allow the diagnosis of hairy cell leukemia. Blood 1985;65:974-83
40. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP. KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989;42:414-21
41. Bliss E, Naien M, Burns J, Bell K, McGee JO'D. Quantitation of macrophages in human breast cancer using monoclonal antibody (EBM11) to human macrophages. (Abstract) J Pathol 1984;143:A6
42. Wisniewski T, Ghiso J, Frangione B. Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 1991;179:1247-54
43. 21 to Gly on the aggregation of a synthetic fragment of the Alzheimer's amyloid β/A4 peptide. Neurosci Lett 1993;161:17-20
44. Fabian H, Szendrei GI, Mantsch HH, Otvos L. Comparative analysis of human and Dutch-type Alzheimer β-amyloid peptides by infrared spectroscopy and circular dichroism. Biochem Biophys Res Commun 1993;191:232-39
45. Clements A, Allsop D, Walsh DM, Williams CH. Aggregation and metal-binding properties of mutant forms of the amyloid Aβ peptide of Alzheimer's disease. J Neurochem 1996;66:740-47
46. Davis J, Van Nostrand WE. Enhanced pathologic properties of Dutch-type mutant amyloid β-protein. Proc Natl Acad Sci USA 1996;93:2996-3000
47. Fraser PE, Nguyen JT, Inouye H, et al. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein. Biochem 1992;31:10716-23
48. Sorimachi K, Craik DJ. Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral hemorrhage with amyloidosis. Eur J Biochem 1994;219:237-251
49. Haan J, Van Broeckhoven C, van Duijn CM, et al. The apolipoprotein E e4 allele does not influence the clinical expression of the amyloid precursor protein gene codon 693 or 692 mutations. Ann Neurol 1994;36:434-37
50. Rozemuller AJM, Roos RAC, Bots GTAM, Kamphorst W, Eikelenboom P, Van Nostrand WE. Distribution of β/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease. Am J Pathol 1993;142:1449-57
51. Schlote W. Die Amyloidnatur der kongophilen, drusigen Entartung der Hirnarterien (Scholz) im Senium. Acta Neuropathol 1965;4:449-68
52. Selkoe DJ. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 1994;17:489-517
53. Wisniewski T, Ghiso J, Frangione B. Alzheimer's disease and soluble Aβ. Neurobiol Aging 1994;15:143-52
54. Prior R, D'Urso D, Frank R, Prikulis I, Pavlakovic G. Experimental deposition of Alzheimer amyloid β-protein in canine leptomeningeal vessels. Neuroreport 1995;6:1747-51
55. Scholz W. Studien zur Pathologie der Hirngefäße II. Die drusige Entartung der Hirnarterien und -capillaren. (Eine Form seniler Gefäßerkrankung). Z ges Neurol Psychiat 1938;162:694-715
56. Davis JB, McMurray HF, Schubert D. The amyloid-β protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Commun 1992;189:1096-1100
57. Klegeris A, Walker DG, McGeer PL. Activation of macrophages by Alzheimer β amyloid peptide. Biochem Biophys Res Commun 1994;199:984-91
58. Kida S, Steart PV, Zhang E-T, Weller RO. Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages. Acta Neuropathol 1993;85:646-52
59. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR. Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 1995;16:737-45
60. Tagliavini F, Giaccone G, Bugiani O, Frangione B. Ubiquitinated neurites are associated with preamyloid and cerebral amyloid β deposits in patients with hereditary cerebral hemorrhage with amyloidosis Dutch type. Acta Neuropathol 1993;85:267-71
61. Maat-Schieman MLC, Radder CM, van Duinen SG, Haan J, Roos RAC. Hereditary cerebral hemorrhage with amyloidosis (Dutch): A model for congophilic plaque-formation in the absence of neurofibrillary pathology. Acta Neuropathol 1994;88:371-78
62. Maat-Schieman MLC, Duinen SG van, Bornebroek M, Haan J, Roos RAC. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): II - A review of histopathological aspects. Brain Pathol 1996;6:115-20
63. London JA, Biegel D, Pachter JS. Neurocytopathic effects of β-amyloid-stimulated monocytes: A potential mechanism for central nervous system damage. Proc Natl Acad Sci USA 1996;93:4147-52
64. Dyrks T, Dyrks E, Masters CL, Beyreuther K. Amyloidogenicity of rodent and human βA4 sequences. FEBS Lett 1993;324:231-36
65. Mrak RE, Sheng JG, Griffin WST. Glial cytokines in Alzheimer's disease: Review and pathogenic implications. Human Pathol 1995;26:816-23
66. Shaffer LM, Shein DS, Brannaman CA, Gambetti P, Brunden KR, Younkin SG, Cohen ML. Processing of neuronally-generated βAPP by macrophages and microglia [abstract]. J Neuropathol Exp Neurol 1993;52:269
67. Verbeek MM, Otte-Höller I, Wesseling P, Ruiter DJ, de Waal RMW. Differential expression of intercellular adhesion molecule-1 (ICAM-1) in the Aβ-containing lesions in brains of patients with dementia of the Alzheimer type. Acta Neuropathol 1996;91:608-15
68. Yamaguchi H, Ishiguro K, Sugihara S, et al. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 1994;88:413-19
69. Goldgaber D, Schwarzman AI, Bhasin R, et al. Sequestration of amyloid β-peptide. Ann NY Sci 1993;695:139-43